Physician profile
Bertram Providence
NPI 1174512057
$9,193.17
in general payments reported to CMS, 2019-2025
10 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,728 · 2020: $647 · 2021: $1,377 · 2022: $284 · 2023: $516 · 2024: $1,435 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,207 · Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,206.59 |
| Food and Beverage | $950.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,145.40 | 2019 | |
| Stryker Corporation | $2,541.78 | 2020-2025 | Mako, Iconix, Salvation |
| Impactortho, INC. | $1,200.00 | 2021 | |
| Sportstek Medical, INC | $582.99 | 2019 | |
| Trimed, INC. | $184.40 | 2024 | |
| Linvatec Corporation | $143.08 | 2023 | Biobrace 23mm |
| Orthofix Medical, INC. | $122.41 | 2023 | Physio-Stim |
| Heron Therapeutics, INC. | $110.00 | 2022 | |
| Bioventus LLC | $88.29 | 2023 | Durolane |
| Medtronic, INC. | $74.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bertram Providence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.